Abstract OT1-02-01: Phase I trial of bicalutamide and ribociclib in androgen receptor-positive triple negative breast cancer by Sharifi, M, Wisinski, KB, Burkard, ME, Tevaarwerk, AJ, Tamkus, D, Chan, N, Truica, C, Danciu, O, Hoskins, K, O'Regan, RM

Get full text

Abstract SP012: Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine signaling inhibitors by Griffiths, JI, Chen, J, Cosgrove, PA, O'Dea, A, Sharma, P, Ma, CX, Trivedi, M, Kalinsky, K, Wisinski, KB, O'Reagan, R, Makhoul, I, Spring, LM, Bardia, A, Adler, FR, Cohen, AL, Chang, JT, Khan, QJ, Bild, AH

Get full text

Abstract OT3-02-06: A phase 1 study of BMN 673 in combination with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782) by Mullvain, JA, Leal, T, Eickhoff, J, Kolesar, JM, Liu, G, DiPaola, RS, Wisinski, KB

Get full text

Abstract OT3-01-03: A phase I trial of the safety and immunogenicity of a DNA plasmid based vaccine (WOKVAC) encoding epitopes derived from three breast cancer antigens (IGFBP2, HE... by Childs, JS, Higgins, DM, DeShong, K, Heckman-Stoddard, BM, Wojtowicz, ME, Stanton, SE, Bailey, HH, Wisinski, KB, Disis, ML

Get full text

Abstract P5-13-03: Prospective study of work limitations in breast cancer patients (pts) undergoing curative chemotherapy (CTx) by Tevaarwerk, AJ, Buhr, KA, Conkright, W, Onitilo, A, Robinson, E, Hegeman, R, Ahuja, H, Kwong, RW, Nanad, R, Dennee, A, Koehn, T, Burkard, ME, Wisinski, KB, Wiegmann, DA, Sesto, ME

Get full text

Abstract P3-02-11: Screening Magnetic Resonance Imaging (MRI) of the breast in women at increased lifetime risk for breast cancer: A retrospective single institution study by Ehsani, S, Strigel, R, Pettke, E, Wilke, L, Szalkucki, L, Tevaarwerk, AJ, Wisinski, KB

Get full text

Abstract P3-12-10: Feasibility of four cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: A Wisconsin oncology network study by Wisinski, KB, Burkard, ME, Njiaju, U, Donohue, S, Hegeman, R, Stella, A, Mansky, P, Shah, V, Goggins, T, Qamar, R, Dietrich, L, Kim, K, Traynor, A, Tevaarwerk, A

Get full text

P4-11-21: A Retrospective Analysis of Women at Increased Lifetime Risk for Breast Cancer: Referral Patterns to Subspecialty Providers, Recommendations and Outcomes by Ehsani, S, Tevaarwerk, A, Wilke, L, Neuman, H, Beckman, C, Becker, J, Stettner, A, Strigel, R, Szalkucki, L, Burkard, M, Wisinski, KB

Get full text

Abstract P2-11-15: Development of a web-based survey tool to assess change in breast cancer (BrCa) survivor knowledge after receipt of cancer treatment summary and survivorship car... by Custer, JL, Rocque, GB, Wisinski, KB, Jones, NR, Donohue, S, Koehn, TM, Champeny, TL, Terhaar, AR, Chen, KB, Peck, KA, Tun, MT, Wiegmann, DA, Sesto, ME, Tevaarwerk, AJ

Get full text

Abstract P6-12-02: Use of cytochrome P450 interacting medications in the setting of adjuvant therapy for breast cancer by Njiaju, UO, Kolesar, JM, Johnston, SA, Eickhoff, JC, Osterby, KR, Poggi, LE, Tevaarwerk, AJ, Millholland, RJ, Oliver, KA, Heideman, JL, Wisinski, KB

Get full text

P5-18-12: Perception, Practice and Toxicity of Adjuvant Treatment of HER2+ Breast Cancer in Wisconsin by Rocque, GB, Onitilo, AA, Engel, JM, Pettke, EN, Boshoven, AM, Zhang, S, Kim, KM, Rishi, S, Waack, B, Wisinski, KB, Tevaarwerk, AJ, Burkard, ME

Get full text